

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.94093910 |
| 2 | endocrine pancreas development (GO:0031018) | 6.93192952 |
| 3 | protein maturation by protein folding (GO:0022417) | 6.72952095 |
| 4 | COPII vesicle coating (GO:0048208) | 6.26970360 |
| 5 | protein retention in ER lumen (GO:0006621) | 6.17265926 |
| 6 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 6.02854899 |
| 7 | peptide hormone processing (GO:0016486) | 5.94320446 |
| 8 | type B pancreatic cell development (GO:0003323) | 5.76635109 |
| 9 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.70467384 |
| 10 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.66497848 |
| 11 | signal peptide processing (GO:0006465) | 5.17560286 |
| 12 | exocrine pancreas development (GO:0031017) | 5.17073998 |
| 13 | glandular epithelial cell differentiation (GO:0002067) | 5.16374271 |
| 14 | glandular epithelial cell development (GO:0002068) | 5.11856958 |
| 15 | positive regulation of calcium ion import (GO:0090280) | 5.10016872 |
| 16 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.05835606 |
| 17 | positive regulation of nuclease activity (GO:0032075) | 4.79615473 |
| 18 | regulation of axon guidance (GO:1902667) | 4.74448492 |
| 19 | vesicle coating (GO:0006901) | 4.67036551 |
| 20 | insulin secretion (GO:0030073) | 4.65640558 |
| 21 | germ cell migration (GO:0008354) | 4.65130145 |
| 22 | short-term memory (GO:0007614) | 4.55258486 |
| 23 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 4.50881009 |
| 24 | positive regulation of catecholamine secretion (GO:0033605) | 4.44410678 |
| 25 | ER overload response (GO:0006983) | 4.44225524 |
| 26 | cellular response to vitamin D (GO:0071305) | 4.43404366 |
| 27 | sequestering of metal ion (GO:0051238) | 4.40695138 |
| 28 | positive regulation of insulin secretion (GO:0032024) | 4.40360928 |
| 29 | regulation of nuclease activity (GO:0032069) | 4.33650652 |
| 30 | detection of calcium ion (GO:0005513) | 4.28075810 |
| 31 | regulation of axon extension involved in axon guidance (GO:0048841) | 4.20816853 |
| 32 | vitamin A metabolic process (GO:0006776) | 4.20189668 |
| 33 | regulation of insulin secretion (GO:0050796) | 4.17683077 |
| 34 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.16316895 |
| 35 | locomotory exploration behavior (GO:0035641) | 4.08945155 |
| 36 | nitric oxide mediated signal transduction (GO:0007263) | 4.08416827 |
| 37 | cellular response to unfolded protein (GO:0034620) | 4.06054952 |
| 38 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 4.04941407 |
| 39 | negative regulation of norepinephrine secretion (GO:0010700) | 4.02074351 |
| 40 | ER-nucleus signaling pathway (GO:0006984) | 3.92358462 |
| 41 | cellular response to topologically incorrect protein (GO:0035967) | 3.91128984 |
| 42 | otic vesicle formation (GO:0030916) | 3.91063594 |
| 43 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.82030893 |
| 44 | regulation of peptide hormone secretion (GO:0090276) | 3.78470956 |
| 45 | negative regulation of insulin secretion (GO:0046676) | 3.76474325 |
| 46 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.75019678 |
| 47 | regulation of peptide secretion (GO:0002791) | 3.72323944 |
| 48 | head development (GO:0060322) | 3.71663522 |
| 49 | parturition (GO:0007567) | 3.69870046 |
| 50 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.69689147 |
| 51 | glucocorticoid biosynthetic process (GO:0006704) | 3.69034947 |
| 52 | phenylpropanoid metabolic process (GO:0009698) | 3.66150437 |
| 53 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.63490770 |
| 54 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.63028679 |
| 55 | peptide hormone secretion (GO:0030072) | 3.58067474 |
| 56 | axon extension involved in axon guidance (GO:0048846) | 3.57714797 |
| 57 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.57714797 |
| 58 | positive regulation of odontogenesis (GO:0042482) | 3.56311333 |
| 59 | regulation of calcium ion import (GO:0090279) | 3.55187195 |
| 60 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.54594842 |
| 61 | negative regulation of catecholamine secretion (GO:0033604) | 3.54061780 |
| 62 | glomerulus development (GO:0032835) | 3.53515988 |
| 63 | synaptic transmission, dopaminergic (GO:0001963) | 3.53077195 |
| 64 | peptidyl-asparagine modification (GO:0018196) | 3.52979065 |
| 65 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.50906198 |
| 66 | peptide secretion (GO:0002790) | 3.50087412 |
| 67 | positive regulation of peptide hormone secretion (GO:0090277) | 3.49792996 |
| 68 | tooth mineralization (GO:0034505) | 3.48636744 |
| 69 | toxin metabolic process (GO:0009404) | 3.47214737 |
| 70 | response to endoplasmic reticulum stress (GO:0034976) | 3.42639706 |
| 71 | positive regulation of peptide secretion (GO:0002793) | 3.41282852 |
| 72 | protein localization to Golgi apparatus (GO:0034067) | 3.40210771 |
| 73 | cell migration involved in heart development (GO:0060973) | 3.39921122 |
| 74 | regulation of hormone secretion (GO:0046883) | 3.32527712 |
| 75 | paraxial mesoderm development (GO:0048339) | 3.32275765 |
| 76 | adrenal gland development (GO:0030325) | 3.29420334 |
| 77 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.28620253 |
| 78 | epithelial cell fate commitment (GO:0072148) | 3.25785370 |
| 79 | positive regulation of digestive system process (GO:0060456) | 3.24540119 |
| 80 | protein N-linked glycosylation (GO:0006487) | 3.24410144 |
| 81 | negative regulation of peptide hormone secretion (GO:0090278) | 3.24386306 |
| 82 | response to unfolded protein (GO:0006986) | 3.23987066 |
| 83 | negative regulation of axon guidance (GO:1902668) | 3.23793605 |
| 84 | regulation of gonadotropin secretion (GO:0032276) | 3.22333141 |
| 85 | inner ear receptor cell development (GO:0060119) | 3.21634184 |
| 86 | induction of positive chemotaxis (GO:0050930) | 3.19242745 |
| 87 | retinal ganglion cell axon guidance (GO:0031290) | 3.17619152 |
| 88 | cellular zinc ion homeostasis (GO:0006882) | 3.15879692 |
| 89 | gamma-aminobutyric acid transport (GO:0015812) | 3.13220579 |
| 90 | response to topologically incorrect protein (GO:0035966) | 3.12548270 |
| 91 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.10796241 |
| 92 | negative regulation of peptide secretion (GO:0002792) | 3.10707900 |
| 93 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.06746534 |
| 94 | endocardial cushion morphogenesis (GO:0003203) | 3.04406117 |
| 95 | presynaptic membrane assembly (GO:0097105) | 3.03138335 |
| 96 | regulation of peptide transport (GO:0090087) | 3.03100234 |
| 97 | response to hexose (GO:0009746) | 3.02845086 |
| 98 | 4-hydroxyproline metabolic process (GO:0019471) | 3.01999755 |
| 99 | cellular response to vitamin (GO:0071295) | 3.01991647 |
| 100 | response to glucose (GO:0009749) | 3.00305075 |
| 101 | astrocyte differentiation (GO:0048708) | 2.99445211 |
| 102 | regulation of glucocorticoid secretion (GO:2000849) | 2.98914163 |
| 103 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.97803221 |
| 104 | negative regulation of circadian rhythm (GO:0042754) | 2.97536292 |
| 105 | hypothalamus development (GO:0021854) | 2.96387830 |
| 106 | Golgi organization (GO:0007030) | 2.95569645 |
| 107 | regulation of energy homeostasis (GO:2000505) | 2.93676070 |
| 108 | notochord development (GO:0030903) | 2.93168787 |
| 109 | positive regulation of hormone secretion (GO:0046887) | 2.92333356 |
| 110 | response to monosaccharide (GO:0034284) | 2.91910190 |
| 111 | mesenchymal cell development (GO:0014031) | 2.89351862 |
| 112 | nonmotile primary cilium assembly (GO:0035058) | 2.87710697 |
| 113 | positive regulation of steroid hormone secretion (GO:2000833) | 2.87041860 |
| 114 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.84158058 |
| 115 | growth hormone secretion (GO:0030252) | 2.83776871 |
| 116 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.83153075 |
| 117 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.82967894 |
| 118 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.80722132 |
| 119 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.80620547 |
| 120 | protein targeting to Golgi (GO:0000042) | 2.80527056 |
| 121 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.79397148 |
| 122 | response to hepatocyte growth factor (GO:0035728) | 2.79397148 |
| 123 | cerebellar Purkinje cell layer development (GO:0021680) | 2.79009597 |
| 124 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.78641417 |
| 125 | hormone secretion (GO:0046879) | 2.77976506 |
| 126 | macroautophagy (GO:0016236) | 2.77596950 |
| 127 | regulation of appetite (GO:0032098) | 2.77356906 |
| 128 | pancreas development (GO:0031016) | 2.75399513 |
| 129 | cellular response to glucagon stimulus (GO:0071377) | 2.74870550 |
| 130 | neuron fate determination (GO:0048664) | 2.74376609 |
| 131 | neural crest cell development (GO:0014032) | 2.73908866 |
| 132 | Golgi vesicle transport (GO:0048193) | 2.72083664 |
| 133 | peptide transport (GO:0015833) | 2.71663818 |
| 134 | chemosensory behavior (GO:0007635) | 2.70949247 |
| 135 | chondrocyte development (GO:0002063) | 2.70121684 |
| 136 | positive regulation of glycolytic process (GO:0045821) | 2.68968322 |
| 137 | digestive tract morphogenesis (GO:0048546) | 2.68855686 |
| 138 | glucose homeostasis (GO:0042593) | 2.68366459 |
| 139 | carbohydrate homeostasis (GO:0033500) | 2.68366459 |
| 140 | behavioral response to ethanol (GO:0048149) | 2.66308477 |
| 141 | pharyngeal system development (GO:0060037) | 2.65207169 |
| 142 | neurotransmitter catabolic process (GO:0042135) | 2.65206589 |
| 143 | hormone transport (GO:0009914) | 2.62777231 |
| 144 | positive regulation of amine transport (GO:0051954) | 2.62734777 |
| 145 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.62170321 |
| 146 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.61897906 |
| 147 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.61634449 |
| 148 | limb bud formation (GO:0060174) | 2.61598450 |
| 149 | postsynaptic membrane organization (GO:0001941) | 2.61298760 |
| 150 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.60506709 |
| 151 | neuronal stem cell maintenance (GO:0097150) | 2.60368742 |
| 152 | outer ear morphogenesis (GO:0042473) | 2.58377812 |
| 153 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.57327033 |
| 154 | exploration behavior (GO:0035640) | 2.56433847 |
| 155 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.55915568 |
| 156 | cGMP-mediated signaling (GO:0019934) | 2.55888897 |
| 157 | negative regulation of vascular permeability (GO:0043116) | 2.55865017 |
| 158 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.55560699 |
| 159 | presynaptic membrane organization (GO:0097090) | 2.55416715 |
| 160 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.51018075 |
| 161 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.51018075 |
| 162 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.51018075 |
| 163 | negative chemotaxis (GO:0050919) | 2.50053589 |
| 164 | cellular response to electrical stimulus (GO:0071257) | 2.49530614 |
| 165 | regulation of monocyte chemotaxis (GO:0090025) | 2.49365863 |
| 166 | negative regulation of leukocyte migration (GO:0002686) | 2.49142693 |
| 167 | spinal cord development (GO:0021510) | 2.49002423 |
| 168 | cGMP biosynthetic process (GO:0006182) | 2.48626081 |
| 169 | cardiac epithelial to mesenchymal transition (GO:0060317) | 2.46629105 |
| 170 | regulation of dopamine secretion (GO:0014059) | 2.46273967 |
| 171 | * vasculature development (GO:0001944) | 2.45853575 |
| 172 | mesenchyme morphogenesis (GO:0072132) | 2.45751179 |
| 173 | radial glial cell differentiation (GO:0060019) | 2.44853030 |
| 174 | axonal fasciculation (GO:0007413) | 2.44795242 |
| 175 | * somite development (GO:0061053) | 2.40484982 |
| 176 | motor neuron axon guidance (GO:0008045) | 2.40221311 |
| 177 | somite rostral/caudal axis specification (GO:0032525) | 2.38106216 |
| 178 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.37681678 |
| 179 | negative regulation of epidermis development (GO:0045683) | 2.36364986 |
| 180 | regulation of gastrulation (GO:0010470) | 2.35245435 |
| 181 | detection of light stimulus involved in visual perception (GO:0050908) | 2.33387709 |
| 182 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.33387709 |
| 183 | neuron recognition (GO:0008038) | 2.31916633 |
| 184 | positive regulation of catenin import into nucleus (GO:0035413) | 2.31122730 |
| 185 | response to BMP (GO:0071772) | 2.30750711 |
| 186 | cellular response to BMP stimulus (GO:0071773) | 2.30750711 |
| 187 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.30236015 |
| 188 | kidney mesenchyme development (GO:0072074) | 2.29339523 |
| 189 | circadian sleep/wake cycle process (GO:0022410) | 2.28751238 |
| 190 | regulation of norepinephrine secretion (GO:0014061) | 2.28439669 |
| 191 | regulation of catecholamine secretion (GO:0050433) | 2.26370522 |
| 192 | nephron epithelium morphogenesis (GO:0072088) | 2.26332479 |
| 193 | nephron tubule morphogenesis (GO:0072078) | 2.26332479 |
| 194 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 2.26033607 |
| 195 | COPI coating of Golgi vesicle (GO:0048205) | 10.1165376 |
| 196 | Golgi transport vesicle coating (GO:0048200) | 10.1165376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.90438649 |
| 2 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.94397659 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.53626479 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 2.41552316 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.34223228 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.32050542 |
| 7 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.29104951 |
| 8 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.08992686 |
| 9 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.04762444 |
| 10 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.03974602 |
| 11 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 2.03523125 |
| 12 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.95096248 |
| 13 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.94463250 |
| 14 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.85998308 |
| 15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.82346967 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.77313811 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.75794242 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.74767333 |
| 19 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.74444787 |
| 20 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.72483724 |
| 21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.72466530 |
| 22 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.72309820 |
| 23 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.71418580 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.69921736 |
| 25 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.67545316 |
| 26 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.63382678 |
| 27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.62322043 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.61701198 |
| 29 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.58544933 |
| 30 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.57369665 |
| 31 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.57369665 |
| 32 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.57369665 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56422642 |
| 34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.56403054 |
| 35 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.56331914 |
| 36 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.55841114 |
| 37 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.54454199 |
| 38 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51717082 |
| 39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50650402 |
| 40 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.50528024 |
| 41 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.50459537 |
| 42 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.50094993 |
| 43 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.48799849 |
| 44 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.48780654 |
| 45 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.48056962 |
| 46 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.47652373 |
| 47 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.43685168 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43059968 |
| 49 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42789965 |
| 50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.39163979 |
| 51 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37928655 |
| 52 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37385258 |
| 53 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.37127996 |
| 54 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37127996 |
| 55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.36795175 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.35807130 |
| 57 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.34500703 |
| 58 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33264813 |
| 59 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.32739316 |
| 60 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.32373072 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32372553 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.31820780 |
| 63 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.31761710 |
| 64 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.31414220 |
| 65 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.29409973 |
| 66 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.29361815 |
| 67 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.29361815 |
| 68 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29350750 |
| 69 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.28912811 |
| 70 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.28674121 |
| 71 | EWS_26573619_Chip-Seq_HEK293_Human | 1.28161694 |
| 72 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.28144199 |
| 73 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26386776 |
| 74 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25841739 |
| 75 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25696433 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25650629 |
| 77 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25083746 |
| 78 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.25062807 |
| 79 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24269362 |
| 80 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.23653254 |
| 81 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.23075783 |
| 82 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.22825895 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22599578 |
| 84 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19190782 |
| 85 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.19152300 |
| 86 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18956339 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18563005 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.18091110 |
| 89 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.18034380 |
| 90 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.16590941 |
| 91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.16333074 |
| 92 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16029035 |
| 93 | * TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.15737554 |
| 94 | * TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.15545314 |
| 95 | * REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.15253909 |
| 96 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14651499 |
| 97 | VDR_22108803_ChIP-Seq_LS180_Human | 1.14598783 |
| 98 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14546769 |
| 99 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14341982 |
| 100 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.14160338 |
| 101 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.12283308 |
| 102 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.11966408 |
| 103 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11763034 |
| 104 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10116474 |
| 105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08586055 |
| 106 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.07748905 |
| 107 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.06576511 |
| 108 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06269793 |
| 109 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05875914 |
| 110 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04826682 |
| 111 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04053377 |
| 112 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03221437 |
| 113 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.02819539 |
| 114 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02492497 |
| 115 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.02021553 |
| 116 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01183763 |
| 117 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00999939 |
| 118 | AR_19668381_ChIP-Seq_PC3_Human | 1.00960361 |
| 119 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.00855230 |
| 120 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00782048 |
| 121 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00705363 |
| 122 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00109369 |
| 123 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.99995474 |
| 124 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.99515851 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99072437 |
| 126 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99072437 |
| 127 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.98942995 |
| 128 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.96378686 |
| 129 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95563799 |
| 130 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.95124017 |
| 131 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93479539 |
| 132 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.91902249 |
| 133 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.91793606 |
| 134 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.91200040 |
| 135 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.90707392 |
| 136 | P300_19829295_ChIP-Seq_ESCs_Human | 0.90592617 |
| 137 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88759302 |
| 138 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.88146359 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.88057972 |
| 140 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87587078 |
| 141 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87094546 |
| 142 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.86526990 |
| 143 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.85764170 |
| 144 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.85631862 |
| 145 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85601160 |
| 146 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85197501 |
| 147 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83942300 |
| 148 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.83005385 |
| 149 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.81977365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 6.09290163 |
| 2 | MP0003011_delayed_dark_adaptation | 4.72448424 |
| 3 | MP0009780_abnormal_chondrocyte_physiolo | 4.56509855 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 4.45808759 |
| 5 | MP0004043_abnormal_pH_regulation | 4.10317383 |
| 6 | MP0010030_abnormal_orbit_morphology | 3.95704754 |
| 7 | MP0002693_abnormal_pancreas_physiology | 3.68066354 |
| 8 | MP0003195_calcinosis | 3.60390687 |
| 9 | MP0002909_abnormal_adrenal_gland | 3.57911626 |
| 10 | MP0000678_abnormal_parathyroid_gland | 3.49380784 |
| 11 | MP0001944_abnormal_pancreas_morphology | 3.45980326 |
| 12 | MP0000013_abnormal_adipose_tissue | 3.31866431 |
| 13 | MP0010386_abnormal_urinary_bladder | 3.11519892 |
| 14 | MP0005379_endocrine/exocrine_gland_phen | 3.03101908 |
| 15 | MP0003136_yellow_coat_color | 2.93010080 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.85530958 |
| 17 | MP0002938_white_spotting | 2.55068875 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.53250888 |
| 19 | MP0003183_abnormal_peptide_metabolism | 2.43720051 |
| 20 | MP0005220_abnormal_exocrine_pancreas | 2.41828168 |
| 21 | MP0000372_irregular_coat_pigmentation | 2.24210899 |
| 22 | MP0006072_abnormal_retinal_apoptosis | 2.12682141 |
| 23 | MP0002896_abnormal_bone_mineralization | 2.08422263 |
| 24 | MP0002928_abnormal_bile_duct | 2.04458066 |
| 25 | MP0000537_abnormal_urethra_morphology | 2.03916302 |
| 26 | MP0003880_abnormal_central_pattern | 1.97242026 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.96549270 |
| 28 | MP0002234_abnormal_pharynx_morphology | 1.93396986 |
| 29 | MP0002078_abnormal_glucose_homeostasis | 1.89646954 |
| 30 | MP0002822_catalepsy | 1.89646545 |
| 31 | MP0003122_maternal_imprinting | 1.89141019 |
| 32 | MP0009278_abnormal_bone_marrow | 1.88089507 |
| 33 | MP0005423_abnormal_somatic_nervous | 1.86788430 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.85552234 |
| 35 | MP0005551_abnormal_eye_electrophysiolog | 1.76805905 |
| 36 | MP0000566_synostosis | 1.71285366 |
| 37 | MP0001293_anophthalmia | 1.69857444 |
| 38 | MP0000462_abnormal_digestive_system | 1.69809685 |
| 39 | MP0000613_abnormal_salivary_gland | 1.69257447 |
| 40 | MP0000003_abnormal_adipose_tissue | 1.66311789 |
| 41 | MP0000778_abnormal_nervous_system | 1.60782817 |
| 42 | MP0001984_abnormal_olfaction | 1.59089326 |
| 43 | MP0002233_abnormal_nose_morphology | 1.58651871 |
| 44 | MP0001270_distended_abdomen | 1.58602387 |
| 45 | MP0003119_abnormal_digestive_system | 1.53856714 |
| 46 | MP0003938_abnormal_ear_development | 1.53710140 |
| 47 | MP0003252_abnormal_bile_duct | 1.53658111 |
| 48 | MP0002697_abnormal_eye_size | 1.53482641 |
| 49 | MP0001299_abnormal_eye_distance/ | 1.50153723 |
| 50 | MP0006276_abnormal_autonomic_nervous | 1.47086558 |
| 51 | MP0000647_abnormal_sebaceous_gland | 1.45595500 |
| 52 | MP0003567_abnormal_fetal_cardiomyocyte | 1.44192884 |
| 53 | MP0009379_abnormal_foot_pigmentation | 1.43801750 |
| 54 | MP0001286_abnormal_eye_development | 1.42522142 |
| 55 | MP0001765_abnormal_ion_homeostasis | 1.42403631 |
| 56 | MP0004264_abnormal_extraembryonic_tissu | 1.41201644 |
| 57 | MP0003329_amyloid_beta_deposits | 1.41049382 |
| 58 | MP0001324_abnormal_eye_pigmentation | 1.38998945 |
| 59 | MP0008789_abnormal_olfactory_epithelium | 1.38314419 |
| 60 | MP0000163_abnormal_cartilage_morphology | 1.37456541 |
| 61 | MP0001879_abnormal_lymphatic_vessel | 1.37271292 |
| 62 | MP0005503_abnormal_tendon_morphology | 1.36864261 |
| 63 | MP0004147_increased_porphyrin_level | 1.35737448 |
| 64 | MP0003937_abnormal_limbs/digits/tail_de | 1.33326270 |
| 65 | MP0005391_vision/eye_phenotype | 1.32264776 |
| 66 | MP0005394_taste/olfaction_phenotype | 1.30486958 |
| 67 | MP0005499_abnormal_olfactory_system | 1.30486958 |
| 68 | MP0000631_abnormal_neuroendocrine_gland | 1.29408369 |
| 69 | MP0002249_abnormal_larynx_morphology | 1.26649750 |
| 70 | MP0006054_spinal_hemorrhage | 1.25373105 |
| 71 | MP0002653_abnormal_ependyma_morphology | 1.25217628 |
| 72 | MP0005377_hearing/vestibular/ear_phenot | 1.24313052 |
| 73 | MP0003878_abnormal_ear_physiology | 1.24313052 |
| 74 | MP0002638_abnormal_pupillary_reflex | 1.22391800 |
| 75 | MP0008961_abnormal_basal_metabolism | 1.21542244 |
| 76 | MP0002163_abnormal_gland_morphology | 1.17390233 |
| 77 | MP0004270_analgesia | 1.16089281 |
| 78 | MP0002127_abnormal_cardiovascular_syste | 1.14395179 |
| 79 | MP0003172_abnormal_lysosome_physiology | 1.14215389 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 1.14209888 |
| 81 | MP0003953_abnormal_hormone_level | 1.14207269 |
| 82 | MP0001348_abnormal_lacrimal_gland | 1.13839701 |
| 83 | MP0001529_abnormal_vocalization | 1.11492233 |
| 84 | MP0003890_abnormal_embryonic-extraembry | 1.10987471 |
| 85 | MP0005257_abnormal_intraocular_pressure | 1.09079743 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 1.07502576 |
| 87 | MP0000751_myopathy | 1.07100099 |
| 88 | MP0000026_abnormal_inner_ear | 1.06598557 |
| 89 | MP0005195_abnormal_posterior_eye | 1.04764817 |
| 90 | MP0003300_gastrointestinal_ulcer | 1.04722391 |
| 91 | MP0002092_abnormal_eye_morphology | 1.03626080 |
| 92 | MP0005275_abnormal_skin_tensile | 1.03552785 |
| 93 | MP0005367_renal/urinary_system_phenotyp | 1.02415310 |
| 94 | MP0000516_abnormal_urinary_system | 1.02415310 |
| 95 | MP0001986_abnormal_taste_sensitivity | 1.02074148 |
| 96 | MP0003121_genomic_imprinting | 1.01601965 |
| 97 | MP0001485_abnormal_pinna_reflex | 1.00593111 |
| 98 | MP0003385_abnormal_body_wall | 1.00104392 |
| 99 | MP0009643_abnormal_urine_homeostasis | 1.00026777 |
| 100 | MP0005248_abnormal_Harderian_gland | 0.99922690 |
| 101 | MP0003755_abnormal_palate_morphology | 0.98778905 |
| 102 | MP0005187_abnormal_penis_morphology | 0.97102112 |
| 103 | MP0003879_abnormal_hair_cell | 0.95747097 |
| 104 | MP0003942_abnormal_urinary_system | 0.94697351 |
| 105 | MP0005171_absent_coat_pigmentation | 0.94432356 |
| 106 | MP0003868_abnormal_feces_composition | 0.93796699 |
| 107 | MP0000538_abnormal_urinary_bladder | 0.92510071 |
| 108 | MP0000049_abnormal_middle_ear | 0.91556442 |
| 109 | MP0002115_abnormal_skeleton_extremities | 0.91307024 |
| 110 | MP0002111_abnormal_tail_morphology | 0.90970214 |
| 111 | MP0005620_abnormal_muscle_contractility | 0.90903017 |
| 112 | MP0004145_abnormal_muscle_electrophysio | 0.90084109 |
| 113 | MP0000428_abnormal_craniofacial_morphol | 0.89591926 |
| 114 | MP0002009_preneoplasia | 0.89066519 |
| 115 | MP0000762_abnormal_tongue_morphology | 0.88925519 |
| 116 | MP0002876_abnormal_thyroid_physiology | 0.87253907 |
| 117 | MP0002752_abnormal_somatic_nervous | 0.86236998 |
| 118 | MP0003279_aneurysm | 0.86178846 |
| 119 | MP0005535_abnormal_body_temperature | 0.85723436 |
| 120 | MP0001919_abnormal_reproductive_system | 0.85601920 |
| 121 | MP0000681_abnormal_thyroid_gland | 0.83598567 |
| 122 | MP0004142_abnormal_muscle_tone | 0.83467907 |
| 123 | MP0002116_abnormal_craniofacial_bone | 0.81525873 |
| 124 | MP0005058_abnormal_lysosome_morphology | 0.81094210 |
| 125 | MP0005508_abnormal_skeleton_morphology | 0.79434305 |
| 126 | MP0003861_abnormal_nervous_system | 0.78940451 |
| 127 | MP0000432_abnormal_head_morphology | 0.78831098 |
| 128 | MP0002177_abnormal_outer_ear | 0.77925536 |
| 129 | MP0002557_abnormal_social/conspecific_i | 0.77311811 |
| 130 | MP0003795_abnormal_bone_structure | 0.76600996 |
| 131 | MP0005636_abnormal_mineral_homeostasis | 0.74792251 |
| 132 | MP0005369_muscle_phenotype | 0.74776475 |
| 133 | MP0003123_paternal_imprinting | 0.74521153 |
| 134 | MP0009384_cardiac_valve_regurgitation | 0.73221232 |
| 135 | MP0000639_abnormal_adrenal_gland | 0.72799628 |
| 136 | MP0008775_abnormal_heart_ventricle | 0.72699576 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.72644766 |
| 138 | MP0004134_abnormal_chest_morphology | 0.71599039 |
| 139 | MP0005595_abnormal_vascular_smooth | 0.71581121 |
| 140 | MP0005375_adipose_tissue_phenotype | 0.71415376 |
| 141 | MP0002295_abnormal_pulmonary_circulatio | 0.70956950 |
| 142 | MP0002108_abnormal_muscle_morphology | 0.69815435 |
| 143 | MP0003935_abnormal_craniofacial_develop | 0.69714762 |
| 144 | MP0009250_abnormal_appendicular_skeleto | 0.69087179 |
| 145 | MP0004272_abnormal_basement_membrane | 0.68969590 |
| 146 | MP0004742_abnormal_vestibular_system | 0.68166461 |
| 147 | MP0001756_abnormal_urination | 0.66104062 |
| 148 | MP0003959_abnormal_lean_body | 0.64114705 |
| 149 | MP0001502_abnormal_circadian_rhythm | 0.63659168 |
| 150 | MP0000534_abnormal_ureter_morphology | 0.63364275 |
| 151 | MP0002933_joint_inflammation | 0.63200811 |
| 152 | MP0010368_abnormal_lymphatic_system | 0.62261576 |
| 153 | MP0005253_abnormal_eye_physiology | 0.61585939 |
| 154 | MP0005448_abnormal_energy_balance | 0.60922784 |
| 155 | MP0008438_abnormal_cutaneous_collagen | 0.60515681 |
| 156 | MP0002089_abnormal_postnatal_growth/wei | 0.58928781 |
| 157 | MP0004036_abnormal_muscle_relaxation | 0.56838104 |
| 158 | MP0004133_heterotaxia | 0.56502825 |
| 159 | MP0000955_abnormal_spinal_cord | 0.56209121 |
| 160 | MP0009672_abnormal_birth_weight | 0.56077576 |
| 161 | MP0004858_abnormal_nervous_system | 0.56057924 |
| 162 | MP0005310_abnormal_salivary_gland | 0.54579251 |
| 163 | MP0002113_abnormal_skeleton_development | 0.54099237 |
| 164 | MP0002734_abnormal_mechanical_nocicepti | 0.53386898 |
| 165 | MP0001346_abnormal_lacrimal_gland | 0.53224884 |
| 166 | MP0002109_abnormal_limb_morphology | 0.52488241 |
| 167 | MP0009703_decreased_birth_body | 0.51552144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.67177841 |
| 2 | Hypoglycemic seizures (HP:0002173) | 7.07157744 |
| 3 | Symptomatic seizures (HP:0011145) | 6.63800407 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.11041890 |
| 5 | Hypoglycemic coma (HP:0001325) | 6.01231532 |
| 6 | Abnormal pancreas size (HP:0012094) | 4.62298274 |
| 7 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.49899520 |
| 8 | Hyperglycemia (HP:0003074) | 4.39535702 |
| 9 | Ketoacidosis (HP:0001993) | 4.37190926 |
| 10 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.27691106 |
| 11 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.27691106 |
| 12 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.16640921 |
| 13 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.04577615 |
| 14 | Septo-optic dysplasia (HP:0100842) | 3.98071363 |
| 15 | Late onset (HP:0003584) | 3.79225240 |
| 16 | Large for gestational age (HP:0001520) | 3.78196856 |
| 17 | Epiphyseal dysplasia (HP:0002656) | 3.67391872 |
| 18 | Decreased circulating renin level (HP:0003351) | 3.60748716 |
| 19 | Generalized aminoaciduria (HP:0002909) | 3.59335250 |
| 20 | Polyphagia (HP:0002591) | 3.33488783 |
| 21 | Hypokalemia (HP:0002900) | 3.33315540 |
| 22 | Mucopolysacchariduria (HP:0008155) | 3.27189049 |
| 23 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.27189049 |
| 24 | Preaxial foot polydactyly (HP:0001841) | 3.22757147 |
| 25 | Anophthalmia (HP:0000528) | 3.18354786 |
| 26 | Osteomalacia (HP:0002749) | 3.13118509 |
| 27 | Thoracolumbar scoliosis (HP:0002944) | 3.08852157 |
| 28 | Dysostosis multiplex (HP:0000943) | 3.02401586 |
| 29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.01627567 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.01627567 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.01627567 |
| 32 | Delayed epiphyseal ossification (HP:0002663) | 2.97245762 |
| 33 | Congenital stationary night blindness (HP:0007642) | 2.94784747 |
| 34 | Short hallux (HP:0010109) | 2.90004831 |
| 35 | Growth hormone deficiency (HP:0000824) | 2.86707190 |
| 36 | Protuberant abdomen (HP:0001538) | 2.84822339 |
| 37 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.79786518 |
| 38 | Turricephaly (HP:0000262) | 2.79691353 |
| 39 | Insulin resistance (HP:0000855) | 2.76604823 |
| 40 | Irregular vertebral endplates (HP:0003301) | 2.76039725 |
| 41 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.75268494 |
| 42 | Genital tract atresia (HP:0001827) | 2.72815580 |
| 43 | Coronal craniosynostosis (HP:0004440) | 2.69731545 |
| 44 | Vaginal atresia (HP:0000148) | 2.68919405 |
| 45 | Increased corneal curvature (HP:0100692) | 2.63512582 |
| 46 | Keratoconus (HP:0000563) | 2.63512582 |
| 47 | Arterial tortuosity (HP:0005116) | 2.63331176 |
| 48 | Absent septum pellucidum (HP:0001331) | 2.62056014 |
| 49 | Abnormality of the intrinsic pathway (HP:0010989) | 2.61401307 |
| 50 | Flat capital femoral epiphysis (HP:0003370) | 2.59574049 |
| 51 | True hermaphroditism (HP:0010459) | 2.56077575 |
| 52 | Abnormality of the vertebral endplates (HP:0005106) | 2.55157506 |
| 53 | Hypoplastic ischia (HP:0003175) | 2.55125659 |
| 54 | Trigonocephaly (HP:0000243) | 2.54897296 |
| 55 | Bilateral microphthalmos (HP:0007633) | 2.54258866 |
| 56 | Soft skin (HP:0000977) | 2.53499705 |
| 57 | Exercise-induced muscle cramps (HP:0003710) | 2.52186901 |
| 58 | Enlarged epiphyses (HP:0010580) | 2.51637127 |
| 59 | Abnormality of the diencephalon (HP:0010662) | 2.50644012 |
| 60 | Abnormality of renin-angiotensin system (HP:0000847) | 2.49506766 |
| 61 | Abnormality of potassium homeostasis (HP:0011042) | 2.45806685 |
| 62 | Gait imbalance (HP:0002141) | 2.44718164 |
| 63 | Unilateral renal agenesis (HP:0000122) | 2.43808037 |
| 64 | Maternal diabetes (HP:0009800) | 2.42921892 |
| 65 | Metaphyseal irregularity (HP:0003025) | 2.42224493 |
| 66 | Vertebral clefting (HP:0008428) | 2.42076663 |
| 67 | Vascular tortuosity (HP:0004948) | 2.40434341 |
| 68 | Hepatoblastoma (HP:0002884) | 2.40368189 |
| 69 | Medial flaring of the eyebrow (HP:0010747) | 2.39378254 |
| 70 | Abnormality of the ischium (HP:0003174) | 2.38899082 |
| 71 | Abdominal distention (HP:0003270) | 2.38645606 |
| 72 | Prominent supraorbital ridges (HP:0000336) | 2.37165924 |
| 73 | Metaphyseal cupping (HP:0003021) | 2.37009148 |
| 74 | Pulmonary artery stenosis (HP:0004415) | 2.36841364 |
| 75 | Abnormality of abdominal situs (HP:0011620) | 2.33376731 |
| 76 | Abdominal situs inversus (HP:0003363) | 2.33376731 |
| 77 | Scotoma (HP:0000575) | 2.32137878 |
| 78 | Ketosis (HP:0001946) | 2.31169667 |
| 79 | Myelomeningocele (HP:0002475) | 2.29870264 |
| 80 | Prominent metopic ridge (HP:0005487) | 2.29440693 |
| 81 | Congenital primary aphakia (HP:0007707) | 2.28477832 |
| 82 | Abnormal tarsal ossification (HP:0008369) | 2.28125547 |
| 83 | Agitation (HP:0000713) | 2.28052758 |
| 84 | Hyperactive renin-angiotensin system (HP:0000841) | 2.27452985 |
| 85 | Hyperparathyroidism (HP:0000843) | 2.27212526 |
| 86 | Abnormal vertebral ossification (HP:0100569) | 2.25453533 |
| 87 | Optic nerve hypoplasia (HP:0000609) | 2.25267771 |
| 88 | Choroideremia (HP:0001139) | 2.24770154 |
| 89 | Abnormality of the aortic arch (HP:0012303) | 2.21930091 |
| 90 | Bicornuate uterus (HP:0000813) | 2.21006632 |
| 91 | Gout (HP:0001997) | 2.17751919 |
| 92 | Abnormality of the metopic suture (HP:0005556) | 2.16901708 |
| 93 | Broad metatarsal (HP:0001783) | 2.15010343 |
| 94 | Abnormality of the septum pellucidum (HP:0007375) | 2.11137527 |
| 95 | Anencephaly (HP:0002323) | 2.08765297 |
| 96 | Abnormality of midbrain morphology (HP:0002418) | 2.08279170 |
| 97 | Molar tooth sign on MRI (HP:0002419) | 2.08279170 |
| 98 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.06337021 |
| 99 | Short tibia (HP:0005736) | 2.06211083 |
| 100 | EEG with generalized epileptiform discharges (HP:0011198) | 2.05659564 |
| 101 | Pancreatic fibrosis (HP:0100732) | 2.03013717 |
| 102 | Renal hypoplasia (HP:0000089) | 2.02876276 |
| 103 | Hypsarrhythmia (HP:0002521) | 2.02800789 |
| 104 | Short 4th metacarpal (HP:0010044) | 2.02278325 |
| 105 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.02278325 |
| 106 | Hypophosphatemia (HP:0002148) | 2.01945438 |
| 107 | Increased circulating renin level (HP:0000848) | 2.00618384 |
| 108 | Papilledema (HP:0001085) | 1.99013768 |
| 109 | Exostoses (HP:0100777) | 1.98853432 |
| 110 | Partial duplication of the phalanx of hand (HP:0009999) | 1.98605507 |
| 111 | Vitreoretinal degeneration (HP:0000655) | 1.98232639 |
| 112 | Epileptiform EEG discharges (HP:0011182) | 1.97397488 |
| 113 | Abnormality of the pubic bones (HP:0003172) | 1.96849785 |
| 114 | Nephrogenic diabetes insipidus (HP:0009806) | 1.96448056 |
| 115 | Beaking of vertebral bodies (HP:0004568) | 1.95193458 |
| 116 | Hyperphosphaturia (HP:0003109) | 1.94612588 |
| 117 | Hyperglycinuria (HP:0003108) | 1.94175241 |
| 118 | Cervical subluxation (HP:0003308) | 1.92415544 |
| 119 | Retinal atrophy (HP:0001105) | 1.92414669 |
| 120 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.91172947 |
| 121 | Distal arthrogryposis (HP:0005684) | 1.91133183 |
| 122 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.90661675 |
| 123 | Broad toe (HP:0001837) | 1.90457611 |
| 124 | Hypokalemic alkalosis (HP:0001949) | 1.90020748 |
| 125 | Irregular epiphyses (HP:0010582) | 1.89503459 |
| 126 | Congenital diaphragmatic hernia (HP:0000776) | 1.88797728 |
| 127 | Hypothermia (HP:0002045) | 1.88754759 |
| 128 | Small epiphyses (HP:0010585) | 1.88507079 |
| 129 | Complement deficiency (HP:0004431) | 1.87043528 |
| 130 | Conjugated hyperbilirubinemia (HP:0002908) | 1.86733700 |
| 131 | Disproportionate short-trunk short stature (HP:0003521) | 1.86616392 |
| 132 | Midline defect of the nose (HP:0004122) | 1.86061549 |
| 133 | Platyspondyly (HP:0000926) | 1.85453056 |
| 134 | Severe short stature (HP:0003510) | 1.85388612 |
| 135 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.84386013 |
| 136 | Rib fusion (HP:0000902) | 1.83939133 |
| 137 | Choanal stenosis (HP:0000452) | 1.82990093 |
| 138 | Bifid tongue (HP:0010297) | 1.82788391 |
| 139 | Genu varum (HP:0002970) | 1.80839104 |
| 140 | Hyperkalemia (HP:0002153) | 1.79988588 |
| 141 | Congenital glaucoma (HP:0001087) | 1.78980098 |
| 142 | Limb hypertonia (HP:0002509) | 1.78502680 |
| 143 | Widely patent fontanelles and sutures (HP:0004492) | 1.77190867 |
| 144 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.76663713 |
| 145 | Thin bony cortex (HP:0002753) | 1.76619246 |
| 146 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.76530204 |
| 147 | Pheochromocytoma (HP:0002666) | 1.76375272 |
| 148 | Chronic hepatic failure (HP:0100626) | 1.75988112 |
| 149 | Reticulocytopenia (HP:0001896) | 1.75964834 |
| 150 | Dysautonomia (HP:0002459) | 1.75838993 |
| 151 | Myokymia (HP:0002411) | 1.75663510 |
| 152 | Hypoplastic pelvis (HP:0008839) | 1.75659791 |
| 153 | Flattened epiphyses (HP:0003071) | 1.75464410 |
| 154 | Broad foot (HP:0001769) | 1.75192493 |
| 155 | Severe Myopia (HP:0011003) | 1.74904518 |
| 156 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.74783655 |
| 157 | Anosmia (HP:0000458) | 1.74567585 |
| 158 | Elevated alkaline phosphatase (HP:0003155) | 1.73863059 |
| 159 | Stenosis of the external auditory canal (HP:0000402) | 1.73014464 |
| 160 | Wide cranial sutures (HP:0010537) | 1.72468628 |
| 161 | Abnormal foot bone ossification (HP:0010675) | 1.72321859 |
| 162 | Cutaneous finger syndactyly (HP:0010554) | 1.72168722 |
| 163 | Type 1 muscle fiber predominance (HP:0003803) | 1.71897253 |
| 164 | Hypoplasia of the fovea (HP:0007750) | 1.70563605 |
| 165 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.70563605 |
| 166 | Poor coordination (HP:0002370) | 1.70492213 |
| 167 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.70272472 |
| 168 | Rocker bottom foot (HP:0001838) | 1.68663831 |
| 169 | Osteoarthritis (HP:0002758) | 1.68456097 |
| 170 | Nausea (HP:0002018) | 1.68037868 |
| 171 | Shallow orbits (HP:0000586) | 1.67914141 |
| 172 | Muscle fiber inclusion bodies (HP:0100299) | 1.67741315 |
| 173 | Epidermoid cyst (HP:0200040) | 1.66412097 |
| 174 | Abnormal eating behavior (HP:0100738) | 1.65447957 |
| 175 | Sclerocornea (HP:0000647) | 1.65344571 |
| 176 | Fibular hypoplasia (HP:0003038) | 1.64947889 |
| 177 | Broad hallux (HP:0010055) | 1.64775615 |
| 178 | Median cleft lip (HP:0000161) | 1.64637574 |
| 179 | Abnormality of the fovea (HP:0000493) | 1.63643656 |
| 180 | Abnormality of purine metabolism (HP:0004352) | 1.63456021 |
| 181 | Mild short stature (HP:0003502) | 1.63176537 |
| 182 | Visual hallucinations (HP:0002367) | 1.62299400 |
| 183 | Exocrine pancreatic insufficiency (HP:0001738) | 1.60731022 |
| 184 | Hypoplasia of the odontoid process (HP:0003311) | 1.59467326 |
| 185 | Flat acetabular roof (HP:0003180) | 1.58859032 |
| 186 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.57944102 |
| 187 | Abnormality of chloride homeostasis (HP:0011422) | 1.56660344 |
| 188 | Abnormal urine phosphate concentration (HP:0012599) | 1.56276700 |
| 189 | Abnormal glycosylation (HP:0012345) | 1.54700399 |
| 190 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.54700399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 7.73461297 |
| 2 | PASK | 6.27085628 |
| 3 | EPHB2 | 3.94436560 |
| 4 | MAPK15 | 3.79686886 |
| 5 | PRKD3 | 3.70439365 |
| 6 | EPHA4 | 3.68903906 |
| 7 | TNIK | 3.58038082 |
| 8 | HIPK2 | 3.05991619 |
| 9 | MAP3K2 | 2.88184725 |
| 10 | OBSCN | 2.86913726 |
| 11 | FRK | 2.66873553 |
| 12 | NTRK3 | 2.37769837 |
| 13 | TAOK3 | 2.13687904 |
| 14 | WNK4 | 2.10543128 |
| 15 | NTRK1 | 2.10440142 |
| 16 | TGFBR2 | 1.95648060 |
| 17 | FLT3 | 1.95244870 |
| 18 | PDGFRA | 1.92066136 |
| 19 | DYRK3 | 1.85825401 |
| 20 | ERN1 | 1.85534349 |
| 21 | EPHA3 | 1.79236780 |
| 22 | PNCK | 1.76908123 |
| 23 | FGFR2 | 1.76081152 |
| 24 | MAP3K1 | 1.73035682 |
| 25 | GRK1 | 1.69963154 |
| 26 | MARK1 | 1.68223275 |
| 27 | SCYL2 | 1.65770336 |
| 28 | TGFBR1 | 1.61598538 |
| 29 | DDR2 | 1.52212600 |
| 30 | DYRK2 | 1.49387045 |
| 31 | PINK1 | 1.48499946 |
| 32 | MET | 1.45397696 |
| 33 | PIK3CA | 1.39931085 |
| 34 | PTK2 | 1.36003681 |
| 35 | TIE1 | 1.35784741 |
| 36 | MKNK1 | 1.35727576 |
| 37 | PLK4 | 1.34899891 |
| 38 | IRAK1 | 1.34774423 |
| 39 | TRIB3 | 1.32630080 |
| 40 | LATS1 | 1.32087291 |
| 41 | PHKG2 | 1.29204390 |
| 42 | PHKG1 | 1.29204390 |
| 43 | MAPK7 | 1.28031059 |
| 44 | WEE1 | 1.27940943 |
| 45 | CDC42BPA | 1.25838667 |
| 46 | PRKCH | 1.22613953 |
| 47 | PTK6 | 1.20489715 |
| 48 | UHMK1 | 1.19564615 |
| 49 | CAMKK2 | 1.19081641 |
| 50 | STK24 | 1.18200170 |
| 51 | SIK1 | 1.17208016 |
| 52 | NTRK2 | 1.15489512 |
| 53 | PAK3 | 1.15257702 |
| 54 | MAP2K7 | 1.12601567 |
| 55 | PRKD2 | 1.09951627 |
| 56 | STK39 | 1.09629795 |
| 57 | DYRK1B | 1.05029642 |
| 58 | AKT3 | 1.04585027 |
| 59 | NUAK1 | 1.03265309 |
| 60 | WNK3 | 1.00877353 |
| 61 | STK16 | 0.98529171 |
| 62 | MAP2K4 | 0.97359614 |
| 63 | STK3 | 0.95839776 |
| 64 | STK38L | 0.94622755 |
| 65 | NEK2 | 0.93553298 |
| 66 | NLK | 0.92970415 |
| 67 | PKN1 | 0.92646536 |
| 68 | BRSK2 | 0.90433303 |
| 69 | VRK1 | 0.88496940 |
| 70 | FGFR1 | 0.88192146 |
| 71 | TYRO3 | 0.87309920 |
| 72 | CDK19 | 0.86951918 |
| 73 | DMPK | 0.85799250 |
| 74 | MAP2K2 | 0.83626714 |
| 75 | MAP4K2 | 0.81425078 |
| 76 | PRKCE | 0.81267012 |
| 77 | IRAK2 | 0.80105109 |
| 78 | IRAK3 | 0.79328662 |
| 79 | FER | 0.79088803 |
| 80 | MAPK13 | 0.77854069 |
| 81 | BCKDK | 0.76957262 |
| 82 | CDK3 | 0.74617925 |
| 83 | PLK2 | 0.71255137 |
| 84 | MKNK2 | 0.68207011 |
| 85 | KSR2 | 0.64406709 |
| 86 | WNK1 | 0.63987517 |
| 87 | ERBB3 | 0.63746124 |
| 88 | MOS | 0.62298234 |
| 89 | EIF2AK3 | 0.61145894 |
| 90 | PLK3 | 0.58083853 |
| 91 | RET | 0.57210410 |
| 92 | RPS6KA4 | 0.55578338 |
| 93 | MAP3K3 | 0.54234883 |
| 94 | KIT | 0.52767477 |
| 95 | PRKACB | 0.52545057 |
| 96 | CAMK2A | 0.52198400 |
| 97 | PRKG1 | 0.51452409 |
| 98 | PDK2 | 0.51244268 |
| 99 | MINK1 | 0.50978806 |
| 100 | MAPK4 | 0.50668133 |
| 101 | BRD4 | 0.48599383 |
| 102 | PRKD1 | 0.48358895 |
| 103 | DYRK1A | 0.47457581 |
| 104 | SGK2 | 0.47440127 |
| 105 | PRKCI | 0.46241114 |
| 106 | BRAF | 0.45478548 |
| 107 | ROCK2 | 0.44938980 |
| 108 | SGK223 | 0.44670275 |
| 109 | SGK494 | 0.44670275 |
| 110 | GSK3A | 0.44491735 |
| 111 | CAMK2D | 0.44152494 |
| 112 | JAK2 | 0.43338331 |
| 113 | ZAK | 0.43113450 |
| 114 | RPS6KA2 | 0.42212969 |
| 115 | TRIM28 | 0.42049814 |
| 116 | PRKAA1 | 0.41914389 |
| 117 | TAF1 | 0.41282983 |
| 118 | NEK6 | 0.41186640 |
| 119 | CDK5 | 0.40555970 |
| 120 | OXSR1 | 0.39476878 |
| 121 | PRKCG | 0.39281538 |
| 122 | CAMK2G | 0.38414050 |
| 123 | PTK2B | 0.38204396 |
| 124 | GRK5 | 0.38066336 |
| 125 | CSNK1A1 | 0.37958629 |
| 126 | BCR | 0.37807556 |
| 127 | PDGFRB | 0.36948365 |
| 128 | JAK3 | 0.36765402 |
| 129 | GRK7 | 0.36233296 |
| 130 | BMPR1B | 0.35885104 |
| 131 | PRKACG | 0.35741595 |
| 132 | ERBB2 | 0.35353602 |
| 133 | CASK | 0.35208136 |
| 134 | PAK2 | 0.34969546 |
| 135 | STK11 | 0.34923750 |
| 136 | PRKACA | 0.34077164 |
| 137 | PRKG2 | 0.33696720 |
| 138 | NME1 | 0.33116443 |
| 139 | IGF1R | 0.32461514 |
| 140 | MAP3K10 | 0.31815565 |
| 141 | SGK3 | 0.31657901 |
| 142 | MTOR | 0.31098350 |
| 143 | ITK | 0.31008394 |
| 144 | TESK1 | 0.30976933 |
| 145 | NEK1 | 0.30107774 |
| 146 | MAP2K1 | 0.29519457 |
| 147 | BMPR2 | 0.27510966 |
| 148 | CAMKK1 | 0.27320622 |
| 149 | MAP3K4 | 0.26659794 |
| 150 | ADRBK1 | 0.26339972 |
| 151 | PRKDC | 0.24487060 |
| 152 | CAMK2B | 0.23885997 |
| 153 | MARK2 | 0.23740294 |
| 154 | MARK3 | 0.22921987 |
| 155 | PRKCA | 0.21553391 |
| 156 | SGK1 | 0.21421549 |
| 157 | RPS6KB1 | 0.21403623 |
| 158 | MAPK14 | 0.20959803 |
| 159 | MAPK10 | 0.20843251 |
| 160 | AKT1 | 0.19946360 |
| 161 | RPS6KA3 | 0.18718572 |
| 162 | LATS2 | 0.18030304 |
| 163 | DAPK2 | 0.17847648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 8.76989042 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.22858250 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.01338641 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 4.09632920 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 3.28766754 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.19380967 |
| 7 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.08614704 |
| 8 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.38940994 |
| 9 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.27633227 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.17610060 |
| 11 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.01210800 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 1.95241226 |
| 13 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.93379239 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 1.81476960 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.80744735 |
| 16 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.78199720 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.76294802 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67075295 |
| 19 | Sulfur relay system_Homo sapiens_hsa04122 | 1.66668061 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.64272055 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61599872 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.50021041 |
| 23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.48338386 |
| 24 | Axon guidance_Homo sapiens_hsa04360 | 1.47683487 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.43448930 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.39906010 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.39763453 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.38182179 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.37870641 |
| 30 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.36565542 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.32708448 |
| 32 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.27864152 |
| 33 | Huntingtons disease_Homo sapiens_hsa05016 | 1.26753595 |
| 34 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.26051569 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25827486 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 1.24239213 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 1.21578491 |
| 38 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.19414174 |
| 39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.18716201 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.17472204 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17252446 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.16940054 |
| 43 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.14287539 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14134411 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13870857 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13502977 |
| 47 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.11845225 |
| 48 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.09856526 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.07140393 |
| 50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.06130133 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05108047 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04816981 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04454392 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02328635 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01401909 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 1.01234483 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 1.00865578 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00329691 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 1.00152008 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98836466 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.98560628 |
| 62 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.98269058 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.97745574 |
| 64 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.97620316 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.97493008 |
| 66 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97295935 |
| 67 | Long-term potentiation_Homo sapiens_hsa04720 | 0.97147267 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96971439 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95490829 |
| 70 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.94093419 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93301079 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.89906030 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.89638566 |
| 74 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87958848 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87415459 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86527617 |
| 77 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.84219865 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84173946 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82996166 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81976307 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81833961 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.81445335 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81109781 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.80535391 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78810177 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78584958 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78193942 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78133432 |
| 89 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.77246018 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.76750788 |
| 91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76060777 |
| 92 | GABAergic synapse_Homo sapiens_hsa04727 | 0.75204571 |
| 93 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74802755 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74550383 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73256987 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.71591104 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69412692 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.68766268 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68312015 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.67165189 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65142871 |
| 102 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64848731 |
| 103 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.64685613 |
| 104 | Nicotine addiction_Homo sapiens_hsa05033 | 0.64621359 |
| 105 | Melanogenesis_Homo sapiens_hsa04916 | 0.64368489 |
| 106 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64283636 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63842765 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62946128 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.60969637 |
| 110 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59296204 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58245368 |
| 112 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.57980241 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57969384 |
| 114 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57468139 |
| 115 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57453061 |
| 116 | Bile secretion_Homo sapiens_hsa04976 | 0.54966753 |
| 117 | Adherens junction_Homo sapiens_hsa04520 | 0.54269779 |
| 118 | Lysine degradation_Homo sapiens_hsa00310 | 0.53929861 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53464660 |
| 120 | Renin secretion_Homo sapiens_hsa04924 | 0.52308408 |
| 121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52028439 |
| 122 | Morphine addiction_Homo sapiens_hsa05032 | 0.51997797 |
| 123 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51183734 |
| 124 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50220087 |
| 125 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.49328604 |
| 126 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49301107 |
| 127 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49014406 |
| 128 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46358221 |
| 129 | Alcoholism_Homo sapiens_hsa05034 | 0.44855303 |
| 130 | ABC transporters_Homo sapiens_hsa02010 | 0.44480427 |
| 131 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43682234 |
| 132 | Prostate cancer_Homo sapiens_hsa05215 | 0.43652820 |
| 133 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42509260 |
| 134 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42333628 |
| 135 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41475328 |
| 136 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38795691 |
| 137 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38637736 |
| 138 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.37512524 |
| 139 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35657699 |
| 140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35565352 |
| 141 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34963800 |
| 142 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33145911 |
| 143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32584439 |
| 144 | Gap junction_Homo sapiens_hsa04540 | 0.31329748 |
| 145 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31162321 |
| 146 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30665608 |
| 147 | Bladder cancer_Homo sapiens_hsa05219 | 0.27586480 |
| 148 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.27230097 |
| 149 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.26879277 |
| 150 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26865550 |
| 151 | Long-term depression_Homo sapiens_hsa04730 | 0.26357964 |
| 152 | Focal adhesion_Homo sapiens_hsa04510 | 0.25740859 |
| 153 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.24469848 |
| 154 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.23081419 |
| 155 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.23010624 |
| 156 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22334222 |
| 157 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22169396 |
| 158 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22069313 |
| 159 | Glioma_Homo sapiens_hsa05214 | 0.21309606 |
| 160 | Salivary secretion_Homo sapiens_hsa04970 | 0.20840770 |
| 161 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20497584 |
| 162 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.19249737 |
| 163 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18939145 |

